CH Biotech R&D Co Ltd

Annual Report

Report overview

The report highlights CH Biotech's fifth consecutive year of record results, with 2025 revenue of NT$1,819,183 thousand, up 11.21% from 2024. It describes product launches and continued expansion in agricultural biotechnology, including peptide products developed from circular-economy materials. The company reported 2025 direct and indirect GHG emissions of 3,992.683 metric tons CO2e after resetting the inventory base year to 2024. Its peptide innovation work received sustainability and biotechnology awards and was linked to SDGs 2, 12, and 13.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 10 April 2026
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Waste
Employees
Women on the board

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services